Jungmin R Choi
@rosajchoi2
UCI visiting scholar | RWE research | Medical devices and medicines outcomes | Early career in Sanofi, MSD, FMC, IMS consulting | Korea Pharmacist MBA | Mom
ID: 175565295
06-08-2010 23:46:49
22 Tweet
50 Followers
489 Following
Dapagliflozin now U.S. FDA approved for ⬇️ HF hosp in #T2DM. Differs from empa (CV death) & cana (MACE). Data support *class* effects across CV endpoints. Differential CV labeling may give payers, clinicians, & pts false impression and suggest otherwise. astrazeneca.com/media-centre/p…
A new study by NYU Grossman School of Medicine found that patients who had a routine #heart procedure did not experience lower rates of cardiac events compared to those treated with medications & lifestyle changes. Learn more about our #ISCHEMIA trial: bit.ly/37gR3dJ @AHA #AHA19 (cont)
Francesco Costa Marco Valgimigli Yoshinobu Onuma David Hildick-Smith Marco Roffi Giuseppe Andò @AIniguezRomo MIЯVΛƬ #IC ༄ 。° Goran Stankovic, MD, PhD Gennaro Giustino, MD Prof. Hector M. Garcia-Garcia On this subject, don't miss this free PCR webinar on PCI and #DAPT strategies for the management of your patients with high bleeding risk (HBR) on Thu 12 Dec 2019 at 4:00pm Paris time (UTC+1) with speakers Marco Valgimigli, Thomas Cuisset & Pieter Smits! ow.ly/vdOA30pXCZQ